LDL-C and TC Mediate the Risk of PNPLA3 Inhibition in Cardiovascular Diseases

• by Genshan Zhang, Wei Jiang, Fangxun He, Jie Fu, Xiangshang Xu, Xuelai Luo, Zhixin Cao

• April 18, 2024

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

• by Kathryn Wighton

• February 23, 2026

• 3 min

Liver Supplements: Big Sales, Limited Evidence

Researchers evaluate how popular liver cleanse products are formulated and promoted in the US online marketplace.

• by Kathryn Wighton

• January 30, 2026

• 3 min

The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction

• by Sergio González-Serrano, Alina-Iuliana Onoiu, Andrea Jiménez-Franco, Vicente Cambra-Cortés, Jordi Camps, Jorge Joven

• April 30, 2026